Livzon Pharmaceutical Group's (HKG:1513, SHE:000513) net profit attributable to shareholders rose 5.5% to 2.06 billion yuan from 1.95 billion yuan a year earlier, according to a Hong Kong Stock Exchange disclosure on Wednesday.

Earnings per share rose 6.7% year on year to 2.24 yuan from 2.10 yuan.

The Chinese pharmaceutical company's operating income fell 5% to 11.8 billion yuan from 12.4 billion yuan in the preceding year, the disclosure said.